You are here

Article Text

Article menu

Download PDFPDF

XML
Rehabilitation medicine
Protocol
Developing the Network Pain Rehabilitation Limburg: a feasibility study protocol
  1. Cynthia Lamper1,
  2. Mariëlle Kroese2,
  3. Albère Köke1,3,
  4. Dirk Ruwaard2,
  5. Jeanine Verbunt1,3,
  6. Ivan Huijnen1,3
  1. 1 Department of Rehabilitation Medicine, Maastricht University CAPHRI School for Public Health and Primary Care, Maastricht, The Netherlands
  2. 2 Department of Health Services Research, Maastricht University CAPHRI School for Public Health and Primary Care, Maastricht, The Netherlands
  3. 3 Kenniscentrum, Adelante, Hoensbroek, The Netherlands
  1. Correspondence to Cynthia Lamper; cynthia.lamper{at}maastrichtuniversity.nl

Abstract

Introduction Patients having chronic musculoskeletal pain (CMP) face challenges as mismatches often exist between the complexity of patient’s pain problem and the rehabilitation treatment offered. This can result in less efficient care for the patient and increased medical shopping. The Network Pain Rehabilitation Limburg (NPRL), a transmural integrated healthcare network, will be designed to improve daily care for patients with CMP. NPRL focusses on improving patient’s level of functioning despite pain by stimulating a biopsychosocial approach given by all involved healthcare professionals. A feasibility study will be performed which will give insight into the barriers and facilitators, perceived value, acceptability and implementation strategies for NPRL.

Methods and analysis This study has a three-phase iterative and incremental design, based on key principles of a user-centred design. Mixed methods will be used in which healthcare professionals and patients involved in NPRL will participate. In phase 1, NPRL will be developed and healthcare professionals educated. Phase 2 focusses on the implementation and phase 3 on the transferability of NPRL. In addition, preliminary data on patient’s work status, general health and participation level will be collected. The qualitative results of each phase will be analysed following the Consolidated Framework for Implementation Research (CFIR) and will be used to refine NPRL in daily practise.

Ethics and dissemination Informed consent will be obtained from all participants. The results of this feasibility study will form the basis for refinement of NPRL and planning of a large-scale process and effect evaluation of the Quadruple Aim outcomes. Dissemination will include publications and presentations at national and international conferences. Ethical approval for this study was granted by the Medical Ethics Committee Z, the Netherlands, METC 17 N-133.

  • rehabilitation medicine
  • musculoskeletal disorders
  • pain management
  • primary care
  • organisation of health services

This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.

https://doi.org/10.1136/bmjopen-2018-025962

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text

    Footnotes

    • Contributors JV, IH and AK conceived the original idea and outline of the study. CL, MK, IH, JV and DR contributed to designing the study. JV, IH and AK were responsible for developing the intervention. CL was the primary writer of the study protocol in collaboration with MK and IH. All authors discussed and commented on draft versions and approved the final version.

    • Funding This work was funded by Health Insurance Companies CZ, VGZ and Achmea, the Netherlands.

    • Competing interests AK, JV and IH report grants from Health Insurance Companies CZ, VGZ and Achmea, during the conduct of the study.

    • Ethics approval Approval from the Medical Ethics Committee Z, the Netherlands, METC 17-N-133.

    • Provenance and peer review Not commissioned; externally peer reviewed.

    • Patient consent for publication Not required.